Lifecore Biomedical, Inc. De (LFCR) Asset Utilization Ratio (2011 - 2025)

Lifecore Biomedical has reported Asset Utilization Ratio for 15 years, with the latest figure at 0.69 in Q2 2025.

• On a quarterly basis, Asset Utilization Ratio rose 34.09% year-over-year to 0.69 in Q2 2025; TTM through May 2025 was 0.69, a 34.09% increase from a year earlier, with the FY2025 full-year figure at 0.52, up 3.37% from the prior year.
• Asset Utilization Ratio was 0.69 for Q2 2025 at Lifecore Biomedical, up from 0.53 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.69 in Q2 2025, with the low at 0.24 in Q2 2021.
• Average Asset Utilization Ratio over 5 years is 0.43, with a median of 0.42 recorded in 2023.
• The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio sank 83.12% in 2021, then soared 65.85% in 2022.
• Over 5 years, Asset Utilization Ratio stood at 0.28 in 2021, then jumped by 44.16% to 0.4 in 2022, then gained by 13.83% to 0.46 in 2023, then advanced by 13.97% to 0.52 in 2024, then jumped by 31.96% to 0.69 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.69 (Q2 2025), 0.53 (Q1 2025), and 0.52 (Q4 2024), per Business Quant data.